Spectroscopic and molecular docking study to understand the binding interaction of rosiglitazone with bovine serum albumin in presence of valsartan

Spectroscopic and molecular docking study to understand the binding interaction of rosiglitazone... Retention of albumin in rosiglitazone treatment and further decrease in microalbuminuria is good indication for diabetic patients. However, the several contradictory reports on its adverse side effects like fluid retention and increase in cardio vascular disease are a matter of concern as it is leading to several ambiguities of rosiglitazone treatment. To reduce cardiovascular side effects of glitazones, antihypertensive drug such as valsartan are employed. Since albumin interaction is an important parameter in pharmacokinetic and drug efficacy, we intended to perform in-vitro experiments on albumin-rosiglitazone/valsartan interaction. Different spectroscopic techniques such as steady state fluorescence, time resolved fluorescence, circular dichroism, dynamic scattering and infrared spectroscopy have been employed to explore the interaction of drug with serum albumin. Stoichiometry of the complex formed between albumin-rosiglitazone was found to increase with increase in temperature suggested self-association of albumin which was confirmed by DLS. Circular dichroism study revealed that the secondary structure of albumin is modified on drug interaction. In silico study suggest that binding rosiglitazone to the BSA site I and II could be the prime reason behind self-association which leads to oligomerisation. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Luminescence Elsevier

Spectroscopic and molecular docking study to understand the binding interaction of rosiglitazone with bovine serum albumin in presence of valsartan

Loading next page...
 
/lp/elsevier/spectroscopic-and-molecular-docking-study-to-understand-the-binding-NhsLG3ihff
Publisher
Elsevier
Copyright
Copyright © 2018 Elsevier B.V.
ISSN
0022-2313
eISSN
1872-7883
D.O.I.
10.1016/j.jlumin.2018.01.017
Publisher site
See Article on Publisher Site

Abstract

Retention of albumin in rosiglitazone treatment and further decrease in microalbuminuria is good indication for diabetic patients. However, the several contradictory reports on its adverse side effects like fluid retention and increase in cardio vascular disease are a matter of concern as it is leading to several ambiguities of rosiglitazone treatment. To reduce cardiovascular side effects of glitazones, antihypertensive drug such as valsartan are employed. Since albumin interaction is an important parameter in pharmacokinetic and drug efficacy, we intended to perform in-vitro experiments on albumin-rosiglitazone/valsartan interaction. Different spectroscopic techniques such as steady state fluorescence, time resolved fluorescence, circular dichroism, dynamic scattering and infrared spectroscopy have been employed to explore the interaction of drug with serum albumin. Stoichiometry of the complex formed between albumin-rosiglitazone was found to increase with increase in temperature suggested self-association of albumin which was confirmed by DLS. Circular dichroism study revealed that the secondary structure of albumin is modified on drug interaction. In silico study suggest that binding rosiglitazone to the BSA site I and II could be the prime reason behind self-association which leads to oligomerisation.

Journal

Journal of LuminescenceElsevier

Published: May 1, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off